RIO DE JANEIRO, Brazil, April 06, 2018 -- TIM Participações S.A. ("Company") (B3:TIMP3) (NYSE:TSU) hereby informs its shareholders and the market in general that it has filed its 2017 annual form (“Form 20-F”) for the calendar year ended in December 31, 2017 at US Securities and Exchange Commission ("SEC").
The Form 20-F is available for download on the Company's Investor Relations website, www.tim.com.br/ir, and, in addition, shareholders may receive a hard copy of the Form 20-F and the complete financial statements, free of charge, by requesting in the following channels: by telephone (+55 21) 4109-4167 or by email [email protected].
Any further information regarding the Form 20-F can be obtained by contacting the Investor Relations Team and/or Mr. Adrian Calaza, Chief Financial Officer and Investor Relations Officer of TIM Participações S.A. through the channels indicated above.
CONTACT INFORMATION TIM Participacoes S.A. Adrian Calaza (+55 21-4109-3742) [email protected] Chief Financial Officer and Investor Relations Officer


Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Google Changes EU Spam Policy Amid Antitrust Scrutiny
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Mercer International Stock Surges 45% on C$20 Million Canada Funding
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 



